Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Akebia Therapeutics, Inc.”

28 pharma patents match "Akebia Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "Akebia Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “Akebia Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12419877

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 11883386

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  3. US 11857543

    Compositions and methods for treating anemia

    Akebia Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  4. US 11844756

    Compositions and methods for treating anemia

    Akebia Therapeutics, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  5. US 11690836

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  6. US 11524939

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

    Akebia Therapeutics, Inc. · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  7. US 11426393

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  8. US 11324734

    Compositions and methods for treating anemia

    Akebia Therapeutics, Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted
  9. US 11267785

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  10. US 11065237

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  11. US 10738010

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  12. US 10729681

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  13. US 10596158

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  14. US 10246416

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted
  15. US 10149842

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted
  16. US 10150734

    Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted
  17. US 9987262

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  18. US 9776969

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  19. US 9701636

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  20. US 9598370

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  21. US 9145366

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  22. US 8940773

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted
  23. US 8865748

    Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer

    Akebia Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  24. US 8722895

    Prolyl hydroxylase inhibitors and method of use

    Akebia Therapeutics, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted